(Q54796811)
Statements
Limited clinical benefit from trastuzumab in recurrent endometrial cancer: two case reports. (English)
I Vergote
I Vandenput
I Vanden Bempt
K Leunen
P Neven
P Berteloot
P Moerman
F Amant
9 October 2008
67
1
46-48